📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. (2024)

First Author: Allen MF

Attributed to: Synthesis and Biology of Prostanoids funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.16435

PubMed Identifier: 38840293

Publication URI: http://europepmc.org/abstract/MED/38840293

Type: Journal Article/Review

Volume: 181

Parent Publication: British journal of pharmacology

Issue: 19

ISSN: 0007-1188